PTC Other Income (Expense) increased by 52145.2% to $466.33M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 33424.4%, from $1.39M to $466.33M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows a downward trend with a -29.9% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$1.94M | $67.24M | $6.18M | -$43.39M | $34.56M | $6.65M | -$2.12M | $55.00K | $2.46M | $3.11M | $2.22M | -$2.22M | -$663.00K | $1.22M | -$322.00K | $1.39M | $2.25M | $11.49M | -$896.00K | $466.33M |
| QoQ Change | — | >999% | -90.8% | -801.6% | +179.7% | -80.8% | -131.9% | +102.6% | >999% | +26.4% | -28.6% | -200.2% | +70.2% | +284.0% | -126.4% | +532.0% | +61.9% | +410.2% | -107.8% | >999% |
| YoY Change | — | — | — | — | >999% | -90.1% | -134.3% | +100.1% | -92.9% | -53.2% | +204.8% | <-999% | -126.9% | -60.8% | -114.5% | +162.5% | +439.7% | +841.8% | -178.3% | >999% |